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Background: The aging of the Italian population will unavoidably lead to a growing number of persons diagnosed
and living with cancer. A comprehensive description of the burden of cancer mortality among Italian elderly
(65-84 years of age) in the last four decades has not been carried out yet. Cancer mortality rates were used to
describe time trends between 1970-2008.
Methods: Mortality counts, provided by the Italian National Institute of Statistics, were grouped according to data
availability: in quinquennia from 1970-74 through 1995-99, and in 2000-03 and 2006-08 groups. Age-standardized
rates (world population) were computed by calendar periods while annual percent changes (APCs) were computed
for elderly and middle aged (35-64 years) people for the period 1995-2008.
Results: The number of cancer deaths in elderly nearly doubled between 1970-74 (31,400 deaths/year in men, and
24,000 in women) and 2006-08 (63,000 deaths/year in men, and 42,000 in women). Overall cancer mortality rates
peaked during the quinquennia 1985-89 and 1990-94 (about 1,500/100,000 in men and 680 in women) and
declined thereafter. Throughout 1995-2008 cancer mortality rates decreased by -1.6%/year in men and -0.9%/year in
women. These decreases were mainly driven by cancers of the stomach, bladder, prostate, and lung (APC = -3.3%,
-2.7%, -2.5%, -2.2%, respectively) in men, and by cancers of the stomach, bladder, and breast (APC = -3.5%, -1.9%,
-1.1%, respectively) in women. Conversely, increases in mortality rates between 1995 and 2008 were recorded for
lung cancer (APC =+0.6%) in women, cutaneous melanoma (APC =+1.7%) in men, and pancreatic cancer
(APC =+0.6% in men and +0.9% in women).
Conclusions: Overall favorable trends in cancer mortality were observed among Italian elderly between 1995 and
2008. Early diagnosis, improved efficacy of anti-cancer treatments and management of comorbidities are the most
likely explanations of these positive observations. However, enduring preventive interventions against the most
common risk factor (e.g. cigarette smoking), early diagnosis, and access to care should be reconsidered and
extended to match the reductions of cancer mortality recorded in the elderly with those in the middle aged.
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It is well known that the incidence of most cancers
increases approximately as the 4th-5th power of age.
However, aging should not be considered an inde-
pendent risk factor but a surrogate of prolonged carcino-
gen exposure [1-3]. In 2008, in Italy, nearly 60% of about
150,000 cancer deaths occurred in the 10.5 million* Correspondence: bidolie@cro.it
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reproduction in any medium, provided the orelderly aged between 65 and 84 years. Elderly population
is expected to increase by 11% in 2020, and by 29% in
2030 [4], and this increase will unavoidably lead to a
growing number of elderly people diagnosed and living
with a neoplastic disease.
Mortality rates from some neoplasms steadily declined
among the whole Italian population up to the last pub-
lished update in 2007 [5,6]. Downward trends were
mainly recorded for cancers of the stomach and intes-
tines in both sexes, and in men only, for lung and other
tobacco-related neoplasms. For some cancer types it istd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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diagnosis programs (e.g. breast and prostate) and/or the
introduction in the clinical practice of new treatments
(e.g. testis, Hodgkin’s lymphoma, or lymphocytic leuke-
mias) contributed to the reduction of cancer mortality.
In the elderly the behavior of some cancers may
become more aggressive (e.g., acute myeloid leukemia,
lymphoma and ovarian cancer) or more indolent (e.g.,
breast and lung cancer) than in the adult age groups
[7,8]. From this view point, the assessment of long term
trends of cancer mortality offers specific clues about
the introduction of early diagnosis modalities, the de-
velopment of new treatment protocols, and competing
causes of mortality (e.g., cardiovascular and neurologic
disorders). A topic that has been poorly investigated in
Italy [7,8].
In the very elderly (≥85 years), the identification of the
precise cause of death is potentially complicated by a
number of common life-threatening comorbidities (i.e.
hypertension, chronic obstructive pulmonary diseases, or
diabetes). Thus, in order to reach meaningful conclu-
sions, analysis was restricted to the elderly.
We took advantage of the availability of computerized
death certificates recorded in Italy over the 1970-2008
period to describe trends in cancer mortality among the
elderly aged 65-84 years.
Methods
Information regarding the underlying cause of death for
the period 1970–2008 was extracted from the database
available on electronic support from the Italian National
Institute of Statistics (ISTAT) [4]. Between 1970 and
2008, three different revisions of the International Clas-
sification of Disease (ICD) were used to code the under-
lying cause of death: the 8th revision from 1970 to 1979
[9]; the 9th revision from 1980 to 2002 [10]; and the
10th revision since 2003 [11]. To improve validity and
comparability of some cancer sites/types throughout
subsequent classifications, we pooled together all oral
cavity and pharynx neoplasms, all intestinal sites, includ-
ing rectum, all non-Hodgkin’s lymphomas, and all leuke-
mias. Deaths were recorded according to the ICD-10 as:
all causes of death (ICD10: A00-Y99), all malignant and
benign cancers (ICD-10: C00-D48), lip, oral cavity and
pharynx (ICD10: C00–C14), esophagus (ICD-10: C15),
stomach (ICD-10: C16), intestines, mainly colon and
rectum (ICD-10:C18–C21), liver (ICD-10:C22.0, C22.2,
C22.3, C22.4, and C22.7), pancreas (ICD-10: C25), larynx
(ICD-10: C32), lung (ICD-10:C33–C34), cutaneous mel-
anoma (ICD-10:C43), prostate (ICD-10: C61), breast
(ICD10: C50), ovary (ICD-10:C56), bladder (ICD-10:
C67), kidney and other urinary sites (ICD-10: C64–C66,
C68), all leukemia (ICD10: C91–C95), Hodgkin’s lymph-
oma (ICD10:C81) and non-Hodgkin’s lymphomas (ICD-10:C82–C85, C96). Resident population by sex, age, and cal-
endar year was abstracted from the ISTAT database [12].
Data were grouped into quinquennia from 1970-74 to
1995-99, and into two shorter periods (2000-2003 and
2006-2008), because the computerization of death certi-
ficates for the years 2004 and 2005 had not been com-
pleted at the time of data analysis. Age-standardized
mortality rates per 100,000 (to the world standard popu-
lation [13]) were calculated in both sexes by grouped
periods and annually between 1995 and 2008 according
to the underlying cause of death. Rates and their corre-
sponding standard errors were calculated using SAS 9.20
(SAS Institute Inc., Cary, NC).
The computation of annual percent change (APC)
[14,15] of mortality rates was restricted to the 1995-
2008 period to specifically quantify the recent impact of
cancer mortality on the elderly and on the middle aged
(35-64 years) populations. APCs were estimated by fit-
ting a linear regression line to the natural logarithm of
annual mortality rates using calendar year as a regressor
variable. This calculation assumes that the mortality
rates changed at a constant rate over the entire
calendar-year interval examined, and the validity of this
assumption was checked by merely examining plotted
curves. Statistical significance was assessed at p < 0.05.Results
The number of cancer deaths and the proportion of
deaths caused by cancer nearly doubled during the study
period among the Italian elderly population (Table 1). In
particular, the proportion increased, in men, from 21.5%
in 1970-74 (31,400 deaths per year from any cancer) to
39.8% in 2006-08 (63,000 deaths/year), and from 16.8%
(24,000 deaths/year) to 32.7% (42,000 deaths/year) in
women. In 2006-2008, half of overall cancer mortality in
the elderly was explained, in both sexes, by few leading
cancers, namely: lung (27.9%); intestines (10.3%); pros-
tate (7.6%) and stomach (6.3%) in men, and breast
(13.8%); intestines (11.8%); lung (10.7%); pancreas (7.5%)
and stomach (5.8%) in elderly women (Table 1).
During the study period, overall cancer mortality rates
peaked during the quinquennia 1985-89 and 1990-94 in
both sexes and declined thereafter (Table 2 and Figure 1).
In elderly men, rates increased from 1,306/100,000 in
1970-74 to nearly 1,500 during the quinquennia 1985-89
and 1990-94, and then dropped to 1,212 in 2006-08. In
elderly women, the rates increased from 671/100,000 in
1970-74 to nearly 680 during the quinquennia 1985-89
and 1990-94, and then dropped to 586 in 2006-08. Be-
tween 1995-2008, APC decreased by -1.6%/year (95%CI:
-1.8;-1.4) in men, and by -0.9%/year (95%CI: -1.0;-0.7) in
women. A large variability in cancer trends was regis-
tered according to sex, period and site/type.
Table 1 Number of deaths of selected cancers by sex according to 1970-74 and 2006-08 periods among elderly
(65-84 years) population; Italy 1970-2008
Cause of death or groups of diseases Period
1970-74 2006-08
Mean number of
deaths per year in
65-84 age group
% on all: deaths+,
cancers°
Mean number of
deaths per year in
65-84 age group
% on all: deaths+,
cancers°
Men
All causes of death 146502 - 158647 -
All cancers, benign and malignant 31435 21.5+ 63160 39.8+
Lip, oral cavity and pharynx 1010 3.2° 1001 1.6°
Esophagus 887 2.8° 783 1.2°
Stomach 6052 19.3° 3981 6.3°
Intestines, mainly colon & rectum 3400 10.8° 6498 10.3°
Liver 541 1.7° 1757 2.8°
Pancreas 934 3.0° 3030 4.8°
Larynx 1045 3.3° 944 1.5°
Lung 6551 20.8° 17639 27.9°
Cutaneous melanoma 54 0.2° 477 0.8°
Prostate 2898 9.2° 4824 7.6°
Bladder 1499 4.8° 2924 4.6°
Kidney 366 1.2° 1539 2.4°
Leukemia 787 2.5° 2015 3.2°
Hodgkin lymphoma 159 0.5° 113 0.2°
Non-Hodgkin lymphoma 293 0.9° 1497 2.4°
Women
All causes of death 142098 - 127897 -
All cancers, benign and malignant 23911 16.8+ 41839 32.7+
Lip, oral cavity and pharynx 214 0.9° 384 0.9°
Esophagus 253 1.1° 245 0.6°
Stomach 4694 19.6° 2434 5.8°
Intestines, mainly colon and rectum 3478 14.5° 4935 11.8°
Liver 495 2.1° 448 1.9°
Pancreas 856 3.6° 3138 7.5°
Larynx 65 0.3° 79 0.2°
Lung 1144 4.8° 4465 10.7°
Cutaneous melanoma 54 0.2° 321 0.8°
Breast 2842 11.9° 5781 13.8°
Ovary 558 2.3° 1764 4.2°
Bladder 415 1.7° 638 1.5°
Kidney 255 1.1° 762 1.8°
Leukemia 634 2.7° 1487 3.6°
Hodgkin lymphoma 125 0.5° 97 0.2°
Non-Hodgkin lymphoma 237 1.0° 1384 3.3°
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tality rates decreased continuously throughout the
whole period. Hodgkin lymphoma mortality declined
after 1975-79. Cancers of the lip, oral cavity andpharynx, bladder, and prostate declined after 1985-89.
Declines after 1990-94 were recorded for cancers of
the liver, lung, and kidney (which leveled-off from
2000-03). After 1995-99 declines were observed for
Table 2 Time trends of selected cancer death rates among elderly and middle aged populations; Italy, 1970-2008
Cause of death
or groups of diseases
Age Standardized Rates (World population)
in elderly (65-84 years) x 100,000
Annual Percent Change





1970-74 1975-79 1980-84 1985-89 1990-94 1995-99 2000-03 2006-08 APC (95% CI) APC (95% CI)
Men
All causes of death 5876,5 5478,3 5193,2 4750,8 4262,2 3857,5 3397,7 2847,8 -2,9* (-3,1;-2,7) -3,1* (-3,2;-2,9)
All cancers, benign and malignant 1305,8 1288,1 1400,6 1495,6 1511,6 1431,1 1343,9 1211,5 -1,6* (-1,8;-1,4) -2,6* (-2,6;-2,5)
Lip, oral cavity and pharynx 41,6 35,2 35,7 35,5 31,6 28,3 24,8 21,0 -2,8* (-3,3;-2,3) -3,2* (-3,8;-2,7)
Esophagus 36,8 33,9 32,4 29,5 27,4 24,2 21,1 16,1 -3,7* (-4,6;-2,9) -4,2* (-4,8;-3,6)
Stomach 248,8 201,0 186,2 162,7 134,0 106,7 91,3 76,8 -3,3* (-3,6;-3,0) -4,0* (-4,4;-3,7)
Intestines, mainly colon and rectum 138,5 139,8 119,9 128,9 132,3 134,2 129,1 123,7 -0,8* (-1,0;-0,6) -1,2* (-1,5;-0,8)
Liver 22,8 29,1 41,4 48,5 68,3 58,7 54,0 35,0 -4,6* (-6,8;-2,4) -6,1* (-8,1;-4,2)
Pancreas 38,6 41,4 47,6 55,5 58,8 57,3 58,5 61,1 +0,6* (+0,4;+0,9) +0,1 (-0,3;+0,4)
Larynx 44,4 43,0 43,1 41,6 35,6 29,9 24,4 18,6 -4,6* (-5,1;-4,0) -4,5* (-5,5;-3,5)
Lung 282,7 329,7 392,0 438,4 456,6 439,4 403,7 347,8 -2,2* (-2,5;-2,0) -3,6* (-3,7;-3,4)
Cutaneous melanoma 2,3 3,2 5,8 6,6 7,5 8,2 9,0 9,8 +1,7* (+0,9;+2,6) -0,4 (-1,4;+0,6)
Prostate 114,5 112,0 115,6 121,0 117,5 106,3 94,7 81,9 -2,5* (-2,9;-2,2) -2,0* (-2,8;-1,3)
Bladder 62,1 70,7 79,6 85,5 83,2 68,2 60,6 52,2 -2,7* (-3,0;-2,3) -2,6* (-3,3;-1,8)
Kidney 15,5 17,3 23,9 30,2 33,7 31,2 29,9 30,0 -0,4* (-0,8;-0,0) -1,8* (-2,2;-1,5)
Leukemia 32,7 35,7 40,2 42,2 41,6 38,9 38,4 38,1 -0,2 (-0,6;+0,2) -2,5* (-3,0;-2,0)
Hodgkin's lymphoma 6,8 6,8 5,7 4,5 3,4 2,6 2,3 2,2 -1,7* (-3,2;-0,2) -3,6* (-5,3;-1,8)
Non-Hodgkin's lymphoma 12,4 11,3 17,0 24,0 29,7 33,1 32,5 28,8 -1,4* (-2,1;-0,6) -3,1* (-4,5;-1,8)
Women
All causes of death 3654,2 3274,1 2965,1 2604,2 2294,1 2031,7 1793,3 1533,4 -2,7* (-3,0;-2,5) -2,2* (-2,4;-2,0)
All cancers, benign and malignant 671,0 646,1 662,7 680,8 678,0 637,6 614,9 585,9 -0,9* (-1,0;-0,7) -1,2* (-1,5;-0,9)
Lip, oral cavity and pharynx 5,9 5,4 5,8 6,1 5,7 5,5 5,5 5,4 -0,2 (-1,2;+0,8) +0,5 (-0,9;+1,8)
Esophagus 6,9 6,8 6,2 5,8 5,0 4,4 4,1 3,4 -2,2* (-3,2;-1,2) -1,7* (-3,2;-0,1)
Stomach 127,1 101,2 86,4 74,2 58,8 46,0 38,4 32,6 -3,5* (-4,0;-3,0) -2,6* (-3,4;-1,7)
Intestines, mainly colon and rectum 94,2 98,4 77,0 79,4 77,3 73,0 69,0 67,0 -0,9* (-1,2;-0,7) -1,4* (-1,9;-0,8)
Liver 14,0 17,7 20,2 18,4 23,0 19,1 17,4 10,4 -5,3* (-7,9;-2,6) -7,7* (-10,1;-5,2)
Pancreas 24,0 27,2 31,0 37,4 39,8 39,6 42,2 43,1 +0,9* (+0,6;+1,2) +1,0* (+0,4;+1,6)
Larynx 2,2 2,1 2,1 1,9 1,8 1,4 1,4 1,1 -1,8 (-4,4;+0,8) -1,1 (-3,2;+1,1)
Lung 33,3 38,6 44,9 52,6 57,7 61,1 63,1 65,3 +0,6* (+0,4;+0,9) +2,5* (+2,1;+2,9)
Cutaneous melanoma 1,6 2,7 4,1 4,5 4,8 4,9 4,7 4,7 -0,3 (-1,4;+0,7) -0,3 (-1,2;+0,7)
















Table 2 Time trends of selected cancer death rates among elderly and middle aged populations; Italy, 1970-2008 (Continued)
Ovary 16,8 18,0 22,2 28,1 29,8 27,4 26,9 27,2 0,0 (-0,6;+0,6) -0,8* (-1,5;-0,2)
Bladder 11,3 12,4 12,9 12,4 12,0 9,4 8,7 7,9 -1,9* (-2,5;-1,2) -1,2 (-3,2;+0,8)
Kidney 7,5 8,2 9,8 11,6 12,0 11,3 11,0 10,4 -0,9* (-1,5;-0,3) -2,4* (-3,5;-1,4)
Leukemia 18,3 20,0 21,8 21,4 22,6 21,0 20,7 20,3 -0,4 (-0,9;+0,2) -3,0* (-3,9;-2,1)
Hodgkin's lymphoma 3,6 4,0 3,3 2,5 2,1 1,4 1,3 1,3 -0,8 (-2,4;+0,9) -2,9* (-5,7;-0,1)
Non-Hodgkin's lymphoma 6,9 6,8 10,0 14,7 19,7 22,6 22,4 18,5 -1,7* (-2,7;-0,7) -3,8* (-4,9;-2,7)


















































































































































































































Intestines, mainly colon and rectum ASR/100.000
Figure 1 Trends of age-adjusted mortality rates (ASR) (world population) of cancers and non-cancers among elderly (65-84 years)
population. Italy, 1970-2008.
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Conversely, increased trends were observed for cancer of
the pancreas and for cutaneous melanoma.
In women, esophagus, larynx, and stomach cancers
declined continuously throughout the entire period,
while intestines cancer, and Hodgkin lymphoma
declined after 1975-79. Lip, oral cavity and pharynx
cancers decreased after 1985-84 (reaching a plateau
from 1995-99 onwards). Cancers that declined after
1990-94 were liver, breast, ovary (that leveled-off since
1995-99), bladder, kidney, and leukemia (stable since
2000-03). Non-Hodgkin lymphoma declined after 1995-
99. By contrast, lung and pancreatic cancer mortality
rates increased throughout the whole period examined.
Cutaneous melanoma increased up to 1995-99 and
leveled-off thereafter.
Furthermore, between 1995 and 2008 in the elderly,
cancer rates showed several statistically significant nega-
tive APCs. In elderly men the highest decreases were
displayed by cancers of the liver, and larynx (APC=
-4.6%/year), followed by cancer of the esophagus (APC=
-3.7%/year), stomach (APC= -3.3%/year), lip, oral cavity
and pharynx (APC= -2.8%/year), bladder (APC= -2.7%/
year), prostate (APC= -2.5%/year), lung (APC= -2.2%/
year), Hodgkin lymphomas (APC= -1.7%/year), non-
Hodgkin lymphomas (APC= -1.4%/year), and intestines
(APC= -0.8%/year). Increases were seen for pancreas
carcinoma (APC=+0.6%/year), cutaneous melanoma
(APC=+1.7%/year), and kidney cancer that leveled-off
from 2000-03. In women the largest decreases were
observed by cancer of the liver (APC= -5.3%/year) fol-
lowed by cancer of the stomach (APC= -3.5%/year),
esophagus (APC= -2.2%/year), bladder (APC= -1.9%/
year), larynx (APC= -1.8%/year), non-Hodgkin lymph-
oma (APC= -1.7%/year), breast (APC= -1.1%/year), and
kidney (APC= -0.9%/year). Increases were displayed by
cancer of the pancreas (APC=+0.9%/year) and lung
(APC=+0.6%/year). Lip, oral cavity and pharynx cancers,
ovary, melanoma, Hodgkin lymphomas and leukemia
showed stable trends.
By comparison with the other age groups, between
1995 and 2008 overall cancer mortality rates declined
for people aged <40 years (-1.7%/year in men and -1.8%/
year in women), and for middle aged (35-64 years)
people (-2.6%/year in men and -1.2%/year in women)
(Table 2) while rates in the very elderly (≥85 years)
people increased in men (+0.6%/year) and decreased in
women (-0.2%/year) (not shown). As compared to the
elderly, middle aged men displayed higher decreases in
cancer mortality for lung, kidney, and leukemia, while
middle aged women showed higher decreases in cancer
mortality for breast, leukemia and non-Hodgkin’s
lymphomas. Conversely, middle aged women presented
higher increases of lung cancer mortality than elderlywomen. The other APCs were similar in elderly and
middle aged people.Discussion
Our investigation of cancer mortality trends among the
Italian elderly population across approximately four dec-
ades (1970-2008) showed an increase of the absolute
number of cancer deaths, but decreases in cancer mor-
tality rates for several sites. These decreases reflected
those observed in four leading cancers in men (stomach,
bladder, prostate, and lung) and three leading cancers in
women (stomach, bladder, and breast). Exceptions to
these favorable trends were the increased mortality rates
for lung cancer in women, cutaneous melanoma in men,
and pancreatic cancer in both sexes. However, the gen-
eral favorable trends of the majority of cancers were still
modest over the same period of time when compared to
the higher drops in mortality observed for diseases of the
circulatory system and respiratory system, (Additional
file 1: Table S1). As compared to middle aged people, the
elderly displayed lower decreases for leukemia, lung and
kidney cancers in men and for leukemia, non-Hodgkin’s
lymphomas, and breast cancer. By contrast, middle aged
women presented higher increases of lung cancer mortal-
ity than elderly women.
The downward trends observed for cancer mortality
rates among Italian elderly between 1995 and 2008 were
generally consistent with those reported over a compar-
able period of time in Japan (1998-2007), Canada (1995-
2004), United States (1996-2005), and England, and
Wales (1997-2006) [16].
Several reasons related to large scale changes in expos-
ure to risk factors and to improvements in diagnosis and
treatment may explain these trends. For instance,
decreases in prevalence of smoking in men caused the
decline of lung cancer incidence and mortality, and par-
tially a decline in bladder, kidney, and larynx cancer
[17,18]. The time shift observed for bladder cancer indi-
cates, in addition to smoking, a reduction in exposures
to occupational carcinogens [18]. Moreover, the decrease
and subsequent plateau reached by kidney cancer indi-
cates that obesity and/or hypertension inhibit further
drops in rates of this cancer [19]. Decreases in alcohol
consumption partly explain the reductions of cancers of
the lip, oral cavity and pharynx, esophagus, and larynx
[20]. In men, smoking reduction hampered the drop of
lip, oral cavity and pharynx, and larynx cancers in the
mid-1980s [20]. Changes in viral hepatitis prevalence
rather than alcohol consumption seemed to explain the
drop of liver cancer, as alcohol related cancers declined
since the 1970s [21]. However, the complexity in differ-
entiating primary and secondary liver cancer in death
certificates requires some caution in the interpretation of
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generally attributed to a healthier diet, improved preser-
vation of foods, and reduced prevalence of Helicobacter
pylori [22]. Advancements in screening and early diagno-
sis and, consequently, effective therapy can chiefly ex-
plain the peak of breast cancer observed in the early
1990s. Ovarian cancer displayed a parallel peak to the
one of breast cancer that leveled-off since the mid-1990s,
a pattern that may be linked to delayed diagnoses [23].
Progresses in surgical techniques, adjuvant therapy, and
declines in exposure to risk factors are likely explanations
for the slight decrease in intestinal cancer over time [24].
Population-based screening for colorectal cancers was
not widely available in Italy at the time of the study;
therefore, it could not influence these trends, while drops
in the mortality for prostate cancer since the mid-1980s
are likely due to therapy advancements.
Although evidence-based data restricted to the elderly
are scanty, it is generally accepted that overall improve-
ments in anti-cancer treatment has contributed to re-
duce cancer mortality also in the elderly. An example is
the early adoption of transurethral resection of the pros-
tate as well as androgen blockage and radiotherapy for
patient with locally advanced disease. Moreover, declines
in mortality rates for prostate cancer have been affected
also by chemotherapy with Docetaxel [25].
Pancreatic cancer mortality increased since the 1970s,
leveled-off in correspondence to the peak of lung cancer
in mid-1990s, to increase thereafter, maybe, in associ-
ation with the increase of diabetes prevalence [26]. Cuta-
neous melanoma is directly linked to excessive sun
exposure. The level-off in women, but not in men, indi-
cates changes in exposure rather than selective therapy
advancements [27]. Finally, therapy advancements were
associated to the peak of Hodgkin lymphoma mortality
in the mid-1970s. Compared with young patients, the
elderly are at an advanced stage, have lower performance
status, and generally have a more aggressive biology of
the disease and poor outcome [28]. The decrease in
mortality for non-Hodgkin lymphoma at the end of
1990s is attributable to improved therapies like the
introduction of Rituximab [29]. Death certificates do not
allow the distinction of various types of leukemia; there-
fore, the observed trends are difficult to interpret.
Cancer death certifications data have some limitations
in accuracy and completeness that should be made clear.
Firstly, the primary site of particular cancers is not
always ascertained by means of death certificates. In
accordance with such drawbacks, some sites were pooled
together: lip, oral cavity and pharynx, colon and rectal
cancers, non-Hodgkin lymphomas, and leukemias.
Moreover, before ICD-10 use, primary liver cancer was
not always distinguishable from metastases of other can-
cers. These limitations were taken into account in theinterpretation of time trends. Secondly, cancer and
comorbidities are extremely common in elderly people
and the percentage of histologically confirmed cancers is
generally lower among them than in younger age groups.
Thus, the identification of the true underlying cause of
death may be difficult, with occurrence of both false
positive and false negative errors. Between 1970 and
2008, three different ICD coding rules were used to indi-
cate the underlying cause of death and the criteria for
malignancy. The changes in the classification of tumors
were overcome by recoding diagnoses according to ICD-
10. The overall increased precision should have inflated
mortality rates over time; however, in this study, the
main groups of diseases showed declines. Thirdly, the
accuracy of mortality data derived from death certificates
depends from coding practices. In Italy, the coding of
the cause of deaths is conducted at national level
according to strict guidelines, also by means of an auto-
mated system, thus limiting the possibility of differential
practices influencing death certification procedures.
Some points can be drawn from the trends of cancer
mortality in the elderly in the last four decades. Firstly,
preventive strategies, smoking in the first place, apply
well to the elderly. Cancer prevention must be further
promoted and targeted to this specific population. Sec-
ondly, the elderly generally present high prevalence of
slowly growing cancers, a life expectancy, and a quality
of life compatible with a benefit from screening or early
diagnosis However, they are frequently excluded from
these benefits. Thirdly, the elderly may be unable to
access care that is otherwise considered standard for
an adult population.
Conclusions
In conclusion our study, focused on the whole Italian
elderly population, showed favorable trends in mortality
rates from 1970 to 2008 for many cancers, although in
absolute terms, the number of cancer deaths doubled.
However, further efforts in prevention, applicability of
screenings, and access to care need to be reconsidered
as the Italian population ages.
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